Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection
about
Flaviviruses in Europe: complex circulation patterns and their consequences for the diagnosis and control of West Nile diseaseIFITM proteins restrict antibody-dependent enhancement of dengue virus infectionFeasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplexDevelopment and Characterization of Monoclonal Antibodies to Yellow Fever Virus and Application in Antigen Detection and IgM Capture Enzyme-Linked Immunosorbent AssayPlant-produced candidate countermeasures against emerging and reemerging infections and bioterror agentsDengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral SerotypesLethal antibody enhancement of dengue disease in mice is prevented by Fc modificationDevelopment of a highly protective combination monoclonal antibody therapy against Chikungunya virusThe structural immunology of antibody protection against West Nile virusStructural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine DevelopmentHuman Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment StepAlternative Complement Pathway Deregulation Is Correlated with Dengue SeverityImpact of Quaternary Organization on the Antigenic Structure of the Tick-Borne Encephalitis Virus Envelope Glycoprotein EEnhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue DiseaseDevelopment of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeysNatural Strain Variation and Antibody Neutralization of Dengue Serotype 3 VirusesPeptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion IntermediateHeterologous Protection against Asian Zika Virus Challenge in Rhesus MacaquesThe complexity of antibody-dependent enhancement of dengue virus infectionA recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virusThe Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and ImmunoprophylaxisIssues related to recent dengue vaccine development.First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodiesMeta-analysis of all immune epitope data in the Flavivirus genus: inventory of current immune epitope data status in the context of virus immunity and immunopathology.DHIM supporting immunologic investigations and the identification of immune correlates of protection.A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein.Specificities of human CD4+ T cell responses to an inactivated flavivirus vaccine and infection: correlation with structure and epitope predictionIn-depth analysis of the antibody response of individuals exposed to primary dengue virus infection.Activation of the innate immune response against DENV in normal non-transformed human fibroblastsStructure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2.NIAID workshop on Flavivirus immunity.Phage display approaches for the isolation of monoclonal antibodies against dengue virus envelope domain III from human and mouse derived libraries.Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination.Dengue virus neutralization in cells expressing Fc gamma receptorsCorrelation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans.Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection.Clinical outcome and genetic differences within a monophyletic Dengue virus type 2 populationPoorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms.Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.Characterization of a Novel Dengue Serotype 4 Virus-Specific Neutralizing Epitope on the Envelope Protein Domain III.
P2860
Q24273313-5765EBCB-BF08-4122-9949-591FB53F27F5Q24311739-1880D824-989D-4702-8FF3-8867FC5C3593Q24737461-684DC6CA-E5F4-4FCD-843D-E4EF5EB2C6F4Q26700079-0B5FAE8A-2B0F-4F78-95BC-53E16F622CCAQ26783107-BB95CA86-9D8D-4BDC-A17B-54CD522ECBB2Q27304342-7B5BDA5D-05BC-4A27-A165-85ECD9B86FD7Q27315772-9EAAD83A-6BB5-4103-AEE1-8989B2B72489Q27335008-C59C2438-ECB3-4330-A1B1-9F97762D8920Q27487955-BB785DE0-B89E-4725-91C4-C27D5A54E64FQ27488364-A2124C8D-CA22-498C-A885-73EDE5713C18Q27488791-31A47750-6E1A-4610-8028-38BD806348E5Q27489374-4A4944CF-6240-4BED-9EE9-35FBE87BD707Q27489515-B8610178-F35F-449D-87F0-BBD19316728AQ27490947-8BA2954A-275C-4B86-ABFD-C137F6A4A934Q27491049-BAAF30CF-694E-4D15-AC19-DDD8816DE493Q27491299-1BA9C8B0-1392-4D6D-8AE0-519AFF0BB12AQ27491339-78B23231-71A9-4888-A07F-DC28FD99D6B2Q27980556-0957C10E-9519-4DD4-92CD-6EF0E86BAA1DQ28250383-B501A78A-9CA4-4824-A508-D272B2F6FCF3Q28740740-333EA824-E94D-4A67-B254-D240890906D9Q28804225-7EB04A79-A11C-484F-8B5E-7FDC5DC0E4E4Q30395396-48BFC2E8-F0CC-43DC-ADE4-E5DF9551F596Q31156754-387B0F01-7E66-4AA2-A0D6-50F25B12EE87Q33610555-4C8FE2CF-DB3D-4C97-AAE6-DF3448E52EE1Q33676842-F1B8A908-A656-44C5-9785-7CF43C56C026Q33802834-EC511811-60C8-4258-BCFF-A206C1253DD1Q33900413-C1A2EB4A-06B2-4B36-92F8-4767E9681432Q33945441-E3522E77-A861-4E80-BEA4-B13B77683A5EQ34113793-494829CC-2C1B-4186-89EA-DDDF6E68C5DEQ34120070-8AC17351-2665-4A3D-B371-CB9485CBF879Q34142353-B5F5E73A-C73F-4190-ADBF-DA08D18D17C3Q34226542-764173EF-A156-45D8-915E-10A5DBE2FC34Q34594111-59F0E4D6-7CFF-45E6-8874-728183135A58Q34746693-6AAA5715-B23B-4133-9687-8ABD22C191DBQ34779065-94E601D6-A9CE-47DF-88A7-27591FC7BCF2Q35133990-A3897564-7E5F-46F1-80D7-4FE7F2F92F8BQ35220195-1EAE0503-3CE6-411C-A8BC-5FB8E0ED4B31Q35531167-04ECB47E-93B0-4798-A74F-E145FCA537ACQ35641205-ACD916D4-098F-42E9-B312-998A4D779D6EQ35796610-0090652E-1F73-4DC4-A4C8-B63D29FCD38A
P2860
Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection
@ast
Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection
@en
Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection
@nl
type
label
Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection
@ast
Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection
@en
Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection
@nl
prefLabel
Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection
@ast
Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection
@en
Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection
@nl
P2860
P3181
P1476
Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection
@en
P2860
P3181
P356
10.1017/S1462399408000665
P577
2008-05-12T00:00:00Z